- home
- about us
- Investment Approach
- Client Service Approach
- Market Analysis Summary
- Mission Statement
- Value Proposition
- Team Biographies
- Firm ADV PDFs
- Form CRS
- Firm Brochure-Part 2A of Form ADV
- Brochure Supplement Amit Stavinsky
- Brochure Supplement Frank Parks
- Brochure Supplement Dominick Savo
- Brochure Supplement Richard Mason
- Brochure Supplement Joe Estes
- Brochure Supplement Jonathan Ezra
- Statement Of Financial Strength
- Job Opportunities
- Letter to Clients
- member log-in
- contact us
Latest News about PEN
Recent news which mentions PEN
JMP Analyst Names 5 Gambling Stocks To Buy On The Dip
June 28, 2022
From Benzinga
From Motley Fool
Despite Seeing Accelerated 2023 Growth, This Analyst Cut Penumbra's Price Target - Here's Why
May 04, 2022
Tickers
PEN
From Benzinga
Earnings Scheduled For May 3, 2022
May 03, 2022
From Benzinga
From Benzinga
From Benzinga
28 Biggest Movers From Yesterday
April 12, 2022
From Benzinga
3 Healthcare Stocks to Buy and Hold for the Next 10 Years
April 06, 2022
From Motley Fool
These 3 Stocks Aren't Large Caps Yet, but They Each Could Make $1 Billion in Sales in 2022
March 25, 2022
From Motley Fool
From Benzinga
Penumbra Posts Mixed Bag Q4 Results, Reports Topline Growth Of 22%
February 23, 2022
Tickers
PEN
From Benzinga
Earnings Scheduled For February 22, 2022
February 22, 2022
From Benzinga
The Week Ahead In Biotech (Feb. 20-26): Reata Awaits FDA Decision, Bausch Health, Moderna Lead Earnings News Flow
February 20, 2022
From Benzinga
Here's Why ShockWave Medical Stock Is Perking Up This Week
January 13, 2022
From Motley Fool
Penumbra Weighs Combination With Shockwave Medical: Bloomberg
January 10, 2022
From Benzinga
Penumbra's Thrombectomy System Shows Safety, Clinical Benefit
November 05, 2021
Tickers
PEN
From Benzinga
The Daily Biotech Pulse: Cerus Climbs On Earnings, Horizon CFO To Retire, Teva Prices Upsized Sustainability-Linked Senior Note Offering
November 03, 2021
From Benzinga
Earnings Scheduled For November 3, 2021
November 03, 2021
From Benzinga
The Week Ahead In Biotech (Oct. 31-Nov. 6): Earnings Pick Up Pace, Eton Awaits Seizure Drug Approval, Kidney Conference, More IPOs In The Pipeline
October 31, 2021
From Benzinga
CEO And President Of Penumbra Trades $4.18 Million In Company Stock
September 16, 2021
Tickers
PEN
From Benzinga
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.